US Stock MarketDetailed Quotes

VYNE VYNE Therapeutics

Watchlist

2.0900
-0.0100-0.48%

Close Jul 23 16:00 ET

30.36MMarket Cap-1756P/E (TTM)

VYNE Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-45.71%-7.98M

13.22%-25.34M

-6.78%-5.14M

27.69%-5.15M

-16.40%-9.57M

39.40%-5.48M

48.20%-29.2M

51.98%-4.81M

59.38%-7.13M

49.41%-8.23M

Net income from continuing operations

-11.15%-6.25M

-22.59%-28.45M

37.78%-6.19M

30.39%-6.58M

-18.66%-10.06M

-220.39%-5.62M

68.35%-23.21M

14.04%-9.95M

55.56%-9.46M

57.46%-8.48M

Operating gains losses

----

-928.59%-12.64M

39.30%280K

-97.28%39K

--40K

Depreciation and amortization

----

--0

----

-33.94%72K

-696.15%-155K

510.71%171K

-57.14%12K

Change In working capital

-172.47%-1.94M

-97.36%60K

-84.91%595K

-40.11%569K

59.34%-392K

56.87%-712K

-52.32%2.28M

429.05%3.94M

161.21%950K

-152.91%-964K

-Change in receivables

-547.00%-1.29M

-96.39%405K

-84.76%482K

90.42%-16K

-39.83%139K

-102.51%-200K

45.41%11.21M

29.22%3.16M

-116.77%-167K

128.95%231K

-Change in inventory

----

--0

----

-14.16%97K

--0

-Change in prepaid assets

----

-51.34%508K

----

--1.04M

--597K

-Change in payables and accrued expense

-19.53%-612K

93.56%-559K

-60.61%993K

-25.96%77K

34.53%-1.12M

94.67%-512K

-224.52%-8.68M

188.71%2.52M

103.36%104K

-155.86%-1.71M

-Change in other current liabilities

---34K

161.32%214K

--214K

--0

71.20%-349K

--0

-416.67%-31K

---86K

Cash from discontinued investing activities

Operating cash flow

-45.71%-7.98M

13.22%-25.34M

-6.78%-5.14M

27.69%-5.15M

-16.40%-9.57M

39.40%-5.48M

48.20%-29.2M

51.98%-4.81M

59.38%-7.13M

49.41%-8.23M

Investing cash flow

Cash flow from continuing investing activities

-171.38%-3.57M

-466.08%-57.35M

-6,235,500.00%-62.35M

-68.26%5M

1,425.51%15.67M

-86K

Net business purchase and sale

--0

-68.09%5M

--0

-68.26%5M

--15.67M

--1K

---86K

--0

Net investment purchase and sale

---3.57M

---62.35M

----

--0

----

Cash from discontinued investing activities

Investing cash flow

-171.38%-3.57M

-466.08%-57.35M

-6,235,500.00%-62.35M

--0

-68.26%5M

1,425.51%15.67M

--1K

---86K

--0

Financing cash flow

Cash flow from continuing financing activities

98.16%-4K

4,884.51%82.39M

39,641.83%82.66M

-80.77%-47K

91.80%-5K

-114.16%-217K

-95.84%1.65M

647.37%208K

99.92%-26K

52.71%-61K

Net common stock issuance

--0

5,534.08%82.82M

8,266,600.00%82.67M

--0

-89.98%156K

-98.07%1.47M

96.55%-1K

--0

---86K

Net preferred stock issuance

--0

-270.62%-360K

--0

---360K

--211K

--0

Proceeds from stock option exercised by employees

69.23%-4K

-139.29%-67K

----

---13K

-105.36%-28K

----

Net other financing activities

----

---47K

----

Cash from discontinued financing activities

Financing cash flow

98.16%-4K

4,884.51%82.39M

39,641.83%82.66M

-80.77%-47K

91.80%-5K

-114.16%-217K

-95.84%1.65M

647.37%208K

99.92%-26K

52.71%-61K

Net cash flow

Beginning cash position

-0.97%30.67M

-27.72%30.98M

-56.43%15.5M

-51.65%20.7M

-40.74%30.28M

-27.72%30.98M

-26.64%42.86M

-32.76%35.58M

-58.84%42.81M

-57.19%51.1M

Current changes in cash

-1,562.59%-11.56M

97.47%-301K

429.68%15.17M

28.16%-5.2M

-15.60%-9.58M

-108.43%-695K

23.67%-11.88M

54.24%-4.6M

85.84%-7.24M

46.05%-8.29M

End cash Position

-36.86%19.12M

-0.97%30.67M

-56.43%15.5M

-51.65%20.7M

-40.74%30.28M

-27.72%30.98M

-32.76%35.58M

-58.84%42.81M

Free cash flow

-45.71%-7.98M

13.22%-25.34M

-6.78%-5.14M

27.69%-5.15M

-16.40%-9.57M

39.40%-5.48M

48.20%-29.2M

51.98%-4.81M

59.38%-7.13M

49.41%-8.23M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-45.71%-7.98M	13.22%-25.34M	-6.78%-5.14M	27.69%-5.15M	-16.40%-9.57M	39.40%-5.48M	48.20%-29.2M	51.98%-4.81M	59.38%-7.13M	49.41%-8.23M
Net income from continuing operations	-11.15%-6.25M	-22.59%-28.45M	37.78%-6.19M	30.39%-6.58M	-18.66%-10.06M	-220.39%-5.62M	68.35%-23.21M	14.04%-9.95M	55.56%-9.46M	57.46%-8.48M
Operating gains losses	----	----	----	----	----	----	-928.59%-12.64M	39.30%280K	-97.28%39K	--40K
Depreciation and amortization	----	--0	--0	--0	----	----	-33.94%72K	-696.15%-155K	510.71%171K	-57.14%12K
Change In working capital	-172.47%-1.94M	-97.36%60K	-84.91%595K	-40.11%569K	59.34%-392K	56.87%-712K	-52.32%2.28M	429.05%3.94M	161.21%950K	-152.91%-964K
-Change in receivables	-547.00%-1.29M	-96.39%405K	-84.76%482K	90.42%-16K	-39.83%139K	-102.51%-200K	45.41%11.21M	29.22%3.16M	-116.77%-167K	128.95%231K
-Change in inventory	----	--0	--0	--0	----	----	-14.16%97K	--0	--0	--0
-Change in prepaid assets	----	----	----	-51.34%508K	----	----	----	----	--1.04M	--597K
-Change in payables and accrued expense	-19.53%-612K	93.56%-559K	-60.61%993K	-25.96%77K	34.53%-1.12M	94.67%-512K	-224.52%-8.68M	188.71%2.52M	103.36%104K	-155.86%-1.71M
-Change in other current liabilities	---34K	161.32%214K	--214K	--0	--0	--0	71.20%-349K	--0	-416.67%-31K	---86K
Cash from discontinued investing activities
Operating cash flow	-45.71%-7.98M	13.22%-25.34M	-6.78%-5.14M	27.69%-5.15M	-16.40%-9.57M	39.40%-5.48M	48.20%-29.2M	51.98%-4.81M	59.38%-7.13M	49.41%-8.23M
Investing cash flow
Cash flow from continuing investing activities	-171.38%-3.57M	-466.08%-57.35M	-6,235,500.00%-62.35M	0	0	-68.26%5M	1,425.51%15.67M	1K	-86K	0
Net business purchase and sale	--0	-68.09%5M	--0	--0	--0	-68.26%5M	--15.67M	--1K	---86K	--0
Net investment purchase and sale	---3.57M	---62.35M	----	----	----	--0	--0	----	----	----
Cash from discontinued investing activities
Investing cash flow	-171.38%-3.57M	-466.08%-57.35M	-6,235,500.00%-62.35M	--0	--0	-68.26%5M	1,425.51%15.67M	--1K	---86K	--0
Financing cash flow
Cash flow from continuing financing activities	98.16%-4K	4,884.51%82.39M	39,641.83%82.66M	-80.77%-47K	91.80%-5K	-114.16%-217K	-95.84%1.65M	647.37%208K	99.92%-26K	52.71%-61K
Net common stock issuance	--0	5,534.08%82.82M	8,266,600.00%82.67M	--0	--0	-89.98%156K	-98.07%1.47M	96.55%-1K	--0	---86K
Net preferred stock issuance	--0	-270.62%-360K	--0	--0	--0	---360K	--211K	--211K	--0	--0
Proceeds from stock option exercised by employees	69.23%-4K	-139.29%-67K	----	----	----	---13K	-105.36%-28K	----	----	----
Net other financing activities	----	----	----	---47K	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	98.16%-4K	4,884.51%82.39M	39,641.83%82.66M	-80.77%-47K	91.80%-5K	-114.16%-217K	-95.84%1.65M	647.37%208K	99.92%-26K	52.71%-61K
Net cash flow
Beginning cash position	-0.97%30.67M	-27.72%30.98M	-56.43%15.5M	-51.65%20.7M	-40.74%30.28M	-27.72%30.98M	-26.64%42.86M	-32.76%35.58M	-58.84%42.81M	-57.19%51.1M
Current changes in cash	-1,562.59%-11.56M	97.47%-301K	429.68%15.17M	28.16%-5.2M	-15.60%-9.58M	-108.43%-695K	23.67%-11.88M	54.24%-4.6M	85.84%-7.24M	46.05%-8.29M
End cash Position	-36.86%19.12M	-0.97%30.67M	-0.97%30.67M	-56.43%15.5M	-51.65%20.7M	-40.74%30.28M	-27.72%30.98M	-27.72%30.98M	-32.76%35.58M	-58.84%42.81M
Free cash flow	-45.71%-7.98M	13.22%-25.34M	-6.78%-5.14M	27.69%-5.15M	-16.40%-9.57M	39.40%-5.48M	48.20%-29.2M	51.98%-4.81M	59.38%-7.13M	49.41%-8.23M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall